Frank Wuest

Frank Wuest

Department of Oncology, University of Alberta

Affiliated withUniversity of Alberta

Research Area

Biography

Frank Wuest has not added Biography.
If you are Frank Wuest and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
<sup>18</sup>F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor (SiFA) for Positron Emission Tomography
Publication title

Cited by 3

2020

Other Publications

Article
Year
Synthesis and cyclooxygenase inhibition of various (aryl-1,2,3-triazole-1-yl)-methanesulfonylphenyl derivatives.

Bioorganic & medicinal chemistry| PubMed ID: 19157881

2009
[Not Available].

Journal of oncology| PubMed ID: 19551155

2009
Iodine-124: a promising positron emitter for organic PET chemistry.

Molecules (Basel, Switzerland)| PubMed ID: 20428073

2010
2010
2011
2011
2011
Radiolabeling of phosphatidylserine-binding peptides with prosthetic groups N-[6-(4-[18F]fluorobenzylidene)aminooxyhexyl]maleimide ([18F]FBAM) and N-succinimidyl-4-[18F]fluorobenzoate ([18F]...

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine| PubMed ID: 21571539

2011
Cyclooxygenase-2 inhibitors: a literature and patent review (2009 - 2010).

Expert opinion on therapeutic patents| PubMed ID: 21714592

2011
Copper-free click chemistry with the short-lived positron emitter fluorine-18.

Organic & biomolecular chemistry| PubMed ID: 21938294

2011
Radiotracers based on technetium-94m.

Current radiopharmaceuticals| PubMed ID: 22191648

2011
Novel 5-substituted 1H-tetrazoles as cyclooxygenase-2 (COX-2) inhibitors.

Bioorganic & medicinal chemistry letters| PubMed ID: 22341941

2012
2012
2012
2012
2012
2013
2013
2013
2013
2013
2013
2013
Radiotracers for molecular imaging of cyclooxygenase-2 (COX-2) enzyme.

Current medicinal chemistry| PubMed ID: 24059237

2013
2013
Positron emission tomography radiotracers for imaging hypoxia.

Journal of labelled compounds & radiopharmaceuticals| PubMed ID: 24285331

2013
2014
2014
2014
2014
2014
18F-Labeled Peptides: The Future Is Bright.

Molecules (Basel, Switzerland)| PubMed ID: 25493636

2014
2015
2015
2015
2015
2014
2015
2016
Targeting lysyl oxidase for molecular imaging in breast cancer.

Breast cancer research : BCR| PubMed ID: 26265048

2015
2015
Synthesis and structural identification of fluorine-18 labeled parathyroid hormone.

Journal of labelled compounds & radiopharmaceuticals| PubMed ID: 26356136

2015
Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine| PubMed ID: 26837339

2016
2016
2016
2016
2016
2016
2016
2016
2016
2017
2017
Implications for breast cancer treatment from increased autotaxin production in adipose tissue after radiotherapy.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 28539367

2017
2017
2018
2018
2018
2018
Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancer-effects of hypoxia.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 29913554

2018
Sulfo-click chemistry with F-labeled thio acids.

Chemical communications (Cambridge, England)| PubMed ID: 30633279

2019
Targeting phosphatidylserine for radionuclide-based molecular imaging of apoptosis.

Apoptosis : an international journal on programmed cell death| PubMed ID: 30684144

2019
2020
Effect of hypoxia on human equilibrative nucleoside transporters hENT1 and hENT2 in breast cancer.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 31601121

2019
2019
2020
2019
2019